Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsDividends payablesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Selectis Health (GBCS) Payables (2017 - 2025)

Selectis Health's Payables history spans 13 years, with the latest figure at $7.2 million for Q4 2025.

  • Quarterly results put Payables at $7.2 million for Q4 2025, down 3.02% from a year ago — trailing twelve months through Dec 2025 was $7.2 million (down 3.02% YoY), and the annual figure for FY2025 was $7.2 million, down 3.02%.
  • Payables for Q4 2025 was $7.2 million at Selectis Health, down from $8.1 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $8.9 million in Q1 2025 to a low of $9990.0 in Q3 2021.
  • The 5-year median for Payables is $6.7 million (2022), against an average of $5.6 million.
  • The sharpest move saw Payables tumbled 99.71% in 2021, then skyrocketed 26290.92% in 2022.
  • Year by year, Payables stood at $179071.0 in 2021, then soared by 2441.73% to $4.6 million in 2022, then skyrocketed by 53.27% to $7.0 million in 2023, then rose by 5.75% to $7.4 million in 2024, then fell by 3.02% to $7.2 million in 2025.
  • According to Business Quant data, Payables over the past three periods came in at $7.2 million, $8.1 million, and $8.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.